Telemedicine, Medication Abortion, and Access After Roe v. Wade
Author:
- 1 August 2022
- journal article
- editorial
- Published by American Public Health Association in American Journal of Public Health
- Vol. 112 (8) , 1086-1088
Abstract
American Journal of Public Health (AJPH) from the American Public Health Association (APHA) Telemedicine, Medication Abortion, and Access After Roe v. Wade, an article from American Journal of Public Health, Vol 112 Issue 8Keywords
This publication has 6 references indexed in Scilit:
- Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰Contraception, 2022
- Association of Travel Distance to Nearest Abortion Facility With Rates of AbortionJAMA Network Open, 2021
- Introduction of telemedicine for medication abortion: Changes in service delivery patterns in two U.S. statesContraception, 2021
- Effectiveness, safety and acceptability of no‐test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort studyBJOG: An International Journal of Obstetrics & Gynaecology, 2021
- Medication Abortion Up to 70 Days of GestationObstetrics & Gynecology, 2020
- Broadband Internet Access Is a Social Determinant of Health!American Journal of Public Health, 2020